CSBR — Champions Oncology Balance Sheet
0.000.00%
Last trade - 00:00- $68.65m
- $66.03m
- $50.16m
- 51
- 53
- 92
- 71
Annual balance sheet for Champions Oncology, fiscal year end - April 30th, USD millions except per share, conversion factor applied.
2020 April 30th | 2021 April 30th | 2022 April 30th | 2023 April 30th | 2024 April 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 8.34 | 4.69 | 9.01 | 10.1 | 2.62 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 4.77 | 6.99 | 9.51 | 8.01 | 9.53 |
| Prepaid Expenses | |||||
| Total Current Assets | 13.5 | 12.6 | 19.7 | 19.5 | 13.6 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 6.79 | 14.6 | 15.4 | 14.5 | 12 |
| Net Goodwill | |||||
| Other Long Term Assets | |||||
| Total Assets | 20.8 | 27.6 | 35.4 | 34.3 | 26.1 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 12.1 | 11.2 | 17.5 | 21.7 | 21.5 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 15.4 | 20.2 | 26.3 | 29.7 | 28 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Total Equity | 5.32 | 7.43 | 9.1 | 4.64 | -1.9 |
| Total Liabilities & Shareholders' Equity | 20.8 | 27.6 | 35.4 | 34.3 | 26.1 |
| Total Common Shares Outstanding |